STOCK TITAN
  1. Home
  2. Sec-filings
  3. KALV
  4. [Form 4] KalVista Pharmaceuticals, Inc. Insider Trading Activity

Christopher Yea of KalVista (KALV) exercises options and sells shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KalVista Pharmaceuticals chief development officer Christopher Yea reported an option exercise paired with an open-market sale of common stock. He exercised employee stock options to acquire 33,800 shares at an exercise price of $7.07 per share, fully exercising that option grant. On the same date, he sold 33,800 common shares in open-market transactions at a weighted average price of $26.7818 per share, with individual trades ranging from $26.78 to $26.79. Following these transactions, Yea directly owns 229,918 shares of KalVista common stock.

Positive

  • None.

Negative

  • None.
Insider Yea Christopher
Role CHIEF DEVELOPMENT OFFICER
Sold 33,800 shs ($905K)
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) 33,800 $0.00 --
Exercise Common Stock 33,800 $7.07 $239K
Sale Common Stock 33,800 $26.7818 $905K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct, null); Common Stock — 263,718 shares (Direct, null)
Footnotes (1)
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.78 to $26.79 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option is 100% vested and exercised.
Shares sold 33,800 shares Open-market sale of KalVista common stock on 2026-05-27
Weighted average sale price $26.7818 per share Multiple sale transactions between $26.78 and $26.79
Option exercise price $7.07 per share Employee stock option for 33,800 shares, fully exercised
Shares owned after transactions 229,918 shares Direct KalVista common stock holdings following reported trades
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Option (Right to Buy) financial
"security_title: "Employee Stock Option (Right to Buy)""
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Yea Christopher
(Last)(First)(Middle)
C/O KALVISTA PHARMACEUTICALS, INC.
200 CROSSING BOULEVARD
(Street)
FRAMINGHAM MASSACHUSETTS 01702
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
KalVista Pharmaceuticals, Inc. [ KALV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF DEVELOPMENT OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/27/2026M33,800A$7.07263,718D
Common Stock05/27/2026S33,800D$26.7818(1)229,918D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$7.0705/27/2026M33,800 (2)05/24/2027Common Stock33,800$00D
Explanation of Responses:
1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.78 to $26.79 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. This option is 100% vested and exercised.
/s/ Benjamin L. Palleiko, Attorney-in-Fact05/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did KalVista (KALV) report for Christopher Yea?

KalVista’s chief development officer Christopher Yea reported an option exercise and matching share sale. He exercised options for 33,800 common shares, then sold 33,800 shares in open-market transactions on the same date, updating his direct ownership position.

How many KalVista (KALV) shares did Christopher Yea sell and at what price?

Christopher Yea sold 33,800 KalVista common shares in the open market. The weighted average sale price was $26.7818 per share, with individual trades executed between $26.78 and $26.79 per share, according to the reported weighted average footnote.

What stock options did Christopher Yea exercise at KalVista (KALV)?

Christopher Yea exercised employee stock options covering 33,800 shares of KalVista common stock. These options had an exercise price of $7.07 per share, and the related footnote states the option is 100% vested and exercised, leaving no remaining balance under that grant.

How many KalVista (KALV) shares does Christopher Yea own after this Form 4?

After the reported transactions, Christopher Yea directly owns 229,918 KalVista common shares. This figure reflects his holdings following the exercise of 33,800 options and the sale of 33,800 shares in open-market transactions on the reported transaction date.

Was Christopher Yea’s KalVista (KALV) sale a weighted average transaction?

Yes. The filing notes the reported sale price is a weighted average. The 33,800 shares were sold in multiple transactions, with individual prices ranging from $26.78 to $26.79 per share, and a weighted average sale price of $26.7818 per share.

Did Christopher Yea fully exercise a KalVista (KALV) stock option grant?

Yes. The Form 4 shows an employee stock option for 33,800 shares with a $7.07 exercise price. A footnote states this option is 100% vested and exercised, and the derivative position shows zero remaining options following the exercise transaction.